FindTrial
Sign In

The accuracy and sensitivity evaluation of metagenomic next generation sequencing (mNGS) in patients at high risk of PJI after joint arthroplasty

The accuracy and sensitivity evaluation of metagenomic next generation sequencing (mGNS) in patients at risk of PJI after joint arthroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067370
Enrollment
Unknown
Registered
2023-01-05
Start date
2023-01-31
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periprosthetic joint infection after hip joint arthroplasty

Interventions

Group 1:no
Group 2:no

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: Since January 2023, adult patients who underwent total hip replacement in our hospital and had a history of purulent infection or hip internal fixation.

Exclusion criteria

Exclusion criteria: The exclusion criteria should not be the reverse range of the inclusion criteria, please fill in again

Design outcomes

Primary

MeasureTime frame
Erythrocyte sedimentation rate;C-reactive protein;Bacteria species detected by NGS;Bacteria species detected by culture methods;White blood cell count;Monocyte count;Globulin;Body mass index;—

Countries

China

Contacts

Public ContactZeng Yi

West China Hospital, Sichuan University

zengyigd@126.com+86 18980602289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026